Cytokeratin positive cells in bone marrow, tumor biologic parameters of the primary tumor and survival in breast cancer patients.

被引：0
|
作者：
Gebauer, G
Fehm, T
Maul, H
Baier, P
Scharf, A
Sohn, C
Jaeger, W
机构：
[1] Hannover Med Sch, D-3000 Hannover, Germany
[2] Univ Tubingen, D-72074 Tubingen, Germany
[3] High Tech Klin, Nurnberg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9517
引用
收藏
页码：839S / 839S
页数：1
相关论文
共 50 条
  • [11] Bisphosphonate treatment of primary breast cancer patients with disseminated tumor cells in the bone marrow.
    Hartkopf, Andreas D.
    Wallwiener, Markus
    Hahn, Markus
    Stefanescu, Diana
    Becker, Sven
    Solomayer, Erich
    Fehm, Tanja
    Brucker, Sara
    Wallwiener, Diethelm
    Taran, Florin-Andrei
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [12] Androgen Receptor Status of disseminated Tumor Cells in the Bone Marrow in Patients with primary Breast Cancer
    Piperek, M.
    Krawczyk, N.
    Meier-Stiegen, F.
    Neubauer, H.
    Lopez-Cotarelo, C.
    Esposito, I
    Fehm, T.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E103 - E103
  • [13] Clinical relevance of detection of tumor cells in the bone marrow of primary breast cancer patients: A review
    Harbeck, N
    Abdulsalam, A
    Janicke, F
    ONKOLOGIE, 1997, 20 (05): : 387 - 392
  • [14] Prognostic impact of tumor cells in the bone marrow of 1338 patients with primary breast cancer.
    Diel, IJ
    Solomayer, EF
    Hahn, M
    Gollan, C
    Schütz, F
    Bastert, G
    ANNALS OF ONCOLOGY, 2000, 11 : 17 - 17
  • [15] Expression of Her2/neu on isolated tumor cells in the bone marrow and on the primary tumor of breast cancer patients
    Rack, BK
    Schoberth, A
    Schindbeck, C
    Schulze, S
    Janni, W
    Heinrigs, M
    Strobl, B
    Jeschke, U
    Sommer, H
    Friese, KI
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S228 - S228
  • [16] A culture step substantially enhances the detection of occult tumor cells in bone marrow of breast cancer patients.
    Spyridonidis, A
    Bernhardt, W
    Behringer, D
    Mertelsmann, R
    Henschler, R
    BLOOD, 1997, 90 (10) : 947 - 947
  • [17] Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients
    Rack, Brigitte
    Zombirt, Ewa
    Trapp, Elisabeth
    Jueckstock, Julia
    Andergassen, Ulrich
    Neugebauer, Julia
    Kost, Bernd
    Weissenbacher, Tobias
    Jeschke, Udo
    Schindlbeck, Christian
    Janni, Wolfgang
    Alunni-Fabbroni, Marianna
    ONCOLOGY, 2016, 90 (04) : 232 - 238
  • [18] Immunohistochemical detection of tumor cells in the bone marrow of breast cancer patients
    Okumura, A
    Tokuda, Y
    Tanaka, M
    Makuuchi, H
    Tajima, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (08) : 480 - 485
  • [19] Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma
    Buchner, A
    Riesenberg, R
    Kotter, I
    Crispin, A
    Hofstetter, A
    Oberneder, R
    JOURNAL OF UROLOGY, 2003, 170 (05): : 1747 - 1751
  • [20] Impact of Disseminated Tumor Cells in Bone Marrow and Circulating Tumor Cells in the Blood of Breast Cancer Patients
    Mueller, V
    Fehm, T.
    Janni, W.
    Pantel, K.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 (12) : 1229 - 1232
12345